We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Surgical Correction of Moderate Ischemic Mitral Regurgitation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00394797
First Posted: November 1, 2006
Last Update Posted: June 1, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shaare Zedek Medical Center
  Purpose
The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Condition Intervention
Moderate Ischemic Mitral Regurgitation Procedure: mitral valve annuloplasty

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Further study details as provided by Shaare Zedek Medical Center:

Primary Outcome Measures:
  • survival at 1,5 and 10 years

Secondary Outcome Measures:
  • event free survival
  • symptoms
  • echocardiographic parameters

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Patients undergoing coronary bypass surgery who have moderate degree of ischemic MR
Criteria

Inclusion Criteria:

  • patients undergoing coronary bypass surgery who have moderate degree of ischemic MR

Exclusion Criteria:

  • etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00394797


Locations
Israel
Shaare Zedek Medical Center
Jerusalem, Israel, 91031
Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Principal Investigator: Shuli Silberman, MD Shaare Zedek Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00394797     History of Changes
Other Study ID Numbers: IMR001
First Submitted: October 31, 2006
First Posted: November 1, 2006
Last Update Posted: June 1, 2011
Last Verified: May 2011

Additional relevant MeSH terms:
Ischemia
Mitral Valve Insufficiency
Pathologic Processes
Heart Valve Diseases
Heart Diseases
Cardiovascular Diseases